Sanofi-Synthelabo (India) Profile
Key Indicators
- Authorised Capital ₹ 43.15 Cr
- Paid Up Capital ₹ 33.41 Cr
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 16.11%
- Profit Growth 91.63%
- Ebitda 60.32%
- Net Worth 16.55%
- Total Assets 15.10%
About Sanofi-Synthelabo (India)
Sanofi-Synthelabo (India) Private Limited (SIPL) is Amalgamated company established on 25 Oct 2002 with its office registered at Mumbai, Maharashtra, India and has been running since 22 Year, 7 Months with a paid up capital of 33.41 Cr. According to MCA records, 3 Directors and 1 Signatories are linked to this company as of 16 Jan 2025.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH2002PTC137682
- Company No.
137682
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2002
- Date of AGM
27 Nov 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Sanofi-Synthelabo (India) Private Limited
Explore comprehensive data for Sanofi-Synthelabo (India) Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Sanofi-Synthelabo (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepa Shah  | Company Secretary | 30-Mar-2017 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhav Karandikar | Additional Director | 02-Feb-2021 | Current |
| Rajaram Narayanan | Director | 01-Jan-2018 | Current |
| Praveen Khullar | Director | 14-Dec-2018 | Current |
Financial Performance of Sanofi-Synthelabo (India).
Sanofi-Synthelabo (India) Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 16.11% increase. The company also saw a substantial improvement in profitability, with a 91.63% increase in profit. The company's net worth Soared by an impressive increase of 16.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanofi-Synthelabo (India)?
In 2020, Sanofi-Synthelabo (India) had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vergo Pharma Research Private LimitedPraveen Khullar is a mutual person
- Vergo Pharma Research Laboratories Private Limited
Praveen Khullar is a mutual person
Alivira Animal Health LimitedRajaram Narayanan is a mutual person
Sanofi India LimitedVaibhav Karandikar is a mutual person
Sequent Scientific LimitedRajaram Narayanan is a mutual person
- Sequent Research Limited
Rajaram Narayanan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanofi-Synthelabo (India)?
Sanofi-Synthelabo (India) has a workforce of 332 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanofi-Synthelabo (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanofi-Synthelabo (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Sanofi-Synthelabo (India)
Recent activity within the organization
- Director Appointment
Vaibhav Vinayak Karandikar was appointed as a Additional Director was appointed as a Additional Director on 02 Feb 2021 & has been associated with this company since 4 years 3 months .
- Annual General Meeting
Sanofi-Synthelabo (India) Private Limited last Annual general meeting of members was held on 27 Nov 2020 as per latest MCA records.
- Balance Sheet
Sanofi-Synthelabo (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai.
- Director Appointment
Praveen Khullar was appointed as a Director was appointed as a Director on 14 Dec 2018 & has been associated with this company since 6 years 5 months .
- Director Appointment
Rajaram Narayanan was appointed as a Director was appointed as a Director on 01 Jan 2018 & has been associated with this company since 7 years 4 months .
- Director Appointment
Deepa Ramniklal Shah was appointed as a Company Secretary was appointed as a Company Secretary on 30 Mar 2017 & has been associated with this company since 8 years 1 month .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Sanofi-Synthelabo (India) Private Limited?
Sanofi-Synthelabo (India) Private Limited was incorporated on 25 Oct 2002.
What is authorized share capital and paid-up capital of Sanofi-Synthelabo (India) Private Limited?
The authorized share capital of Sanofi-Synthelabo (India) Private Limited is ₹ 43.15 Cr and paid-up capital is ₹ 33.41 Cr.
Who are the current board members & directors of Sanofi-Synthelabo (India) Private Limited?
Currently 4 directors are associated with Sanofi-Synthelabo (India) Private Limited.
- Rajaram Narayanan
- Praveen Khullar
- Vaibhav Vinayak Karandikar
- Deepa Ramniklal Shah
What is the registered address of Sanofi-Synthelabo (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Sanofi-Synthelabo (India) Private Limited is Sanofi House Cts No.117-B L T Business Park Saki Vihar Road, Powai India, Mumbai, Maharashtra, 400072.
What is the corporate identification number (CIN) and company number of Sanofi-Synthelabo (India) Private Limited?
The corporate identification number (CIN) of Sanofi-Synthelabo (India) Private Limited is U24230MH2002PTC137682 and the company number is 137682 as per Ministry of Corporate Affairs (MCA).
What is the official website of Sanofi-Synthelabo (India) Private Limited?
The Official website of Sanofi-Synthelabo (India) Private Limited is https://www.sanofi.com
What has been the recent revenue trend for Sanofi-Synthelabo (India) Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Sanofi-Synthelabo (India) Private Limited has risen by 16.11%.
How many employees does Sanofi-Synthelabo (India) Private Limited currently have?
As Per 2020 financial reports, 332 employees are currently employed by Sanofi-Synthelabo (India) Private Limited.
What change has been observed in the net worth of Sanofi-Synthelabo (India) Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Sanofi-Synthelabo (India) Private Limited has experienced an upsurge of 16.55%.
When was the last Balance Sheet of Sanofi-Synthelabo (India) Private Limited filed with the ROC?
The most recent Balance Sheet for Sanofi-Synthelabo (India) Private Limited was filed with the ROC on 31 Mar 2020.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Shailesh AyyangarManaging Director
Charles BillardDirectorOC
Olivier CharmeilDirectorEB
Eric BrisCasual Vacancy DirectorMD
Michel DargentolleCasual Vacancy DirectorFD
Francois DuhaldeCasual Vacancy DirectorFB
Francois BriensAdditional DirectorAO
Antoine OrtoliCasual Vacancy Director
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India